The ingredients manufacturer Actylis has opened a new 30,000-square-foot facility in the city of Eugene, OR.
Actylis CEO Gilles Cottier said in a statement the new site will allow the company to manufacture APIs and intermediates for clinical trials — and on a commercial scale.
“We designed...
